AVLX-125 , CAS No.1786434-31-8

CAS: 1786434-31-8 Cat. No.: A1437516 Formula: C₆₂H₁₀₄N₁₀O₂₉ Peso molecolare: 1453.54

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Panoramica

AVLX-125 (UCCB01-125) is a PSD-95 and PDZ domain inhibitor with K d value of 10 nM. AVLX-125 can be used in the study of inflammatory pain.

Specifications

Condizioni di conservazione di stoccaggio

Store at -20°C

Spedito in

Ice chest + Ice pads

Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.

Tipo di azione

INHIBITOR

Nomi e identificatori

• Peso molecolare: 1453.54

Application Protocols

Item-specific, validated protocols are not provided for AVLX-125.

General usage guidance for small-molecule screening (not item-specific):

• Stock preparation: dissolve in anhydrous DMSO to 10–50 mM. Vortex/sonicate; warm gently if needed. Record concentration by weight-in/volume or quantitative NMR if precision is required.
• Plate handling: dispense using acoustic or low-volume pipetting. Include vehicle controls matched for final DMSO percentage (commonly 0.1–1% v/v).
• Assay deployment: pre-check for aggregation (e.g., detergent addition), autofluorescence/inner filter effects for optical assays, and redox interference for peroxidase-coupled readouts.
• Stability: minimize freeze–thaw by aliquoting. Track bench-time and light exposure; re-check purity by LC–MS if anomalous results emerge.

Consult your internal SOPs and the CoA/SDS for any additional item- and lot-specific recommendations.

Biological Roles

Item-specific biological targets and mechanisms are not provided for AVLX-125. Without a disclosed structure or target annotation, biological roles cannot be ascribed to this item.

General guidance for small-molecule library members (not item-specific):

• Use cases: tool compounds for pathway interrogation, high-throughput screening (HTS), and hit/lead validation. Activities are assay- and target-dependent and must be established experimentally.
• Off-target assessment: secondary pharmacology and counterscreens (e.g., cytotoxicity, aggregation, redox cycling) are essential to triage false positives.
• Physicochemical profiling: once structure is known, derive clogP, pKa, TPSA, and solubility to rationalize permeability and target class suitability.

Note: This product is for research use only and is not intended for diagnostic or therapeutic applications.

Buffer Applications

AVLX-125 is a small-molecule library compound and is not a buffering agent. No item-specific buffer system information is provided.

Practical note (general, not item-specific):

• When dosing into buffers, prepare a DMSO (or suitable solvent) stock and dilute into the assay buffer with thorough mixing to avoid local supersaturation and precipitation. Maintain a consistent final co-solvent percentage across controls and treated samples.

For buffer recipes and pH ranges, select established buffering systems (e.g., phosphate, HEPES, Tris) as appropriate for your assay; AVLX-125 itself does not serve as a buffer component.

Green Alternatives

Item-specific green chemistry metrics (e.g., solvent class, EHS profile, life-cycle data) are not available for AVLX-125 without structural information. The following is general guidance for handling small molecules more sustainably:

• Solvent strategy (general):
  • Favor greener solvents for dissolution and workup when compatible: 2-MeTHF, CPME, EtOAc, MeOH, IPA, propylene carbonate. Reserve DCM, DMF, NMP only when necessary.
• Stock solution choices:
  • If high DMSO usage is required for screening, minimize stock concentrations to what’s operationally needed and optimize plate maps to reduce waste. Consider water-miscible greener co-solvents (e.g., EtOH) where assay-tolerant.
• Energy and storage:
  • Consolidate cold storage and reduce freeze–thaw cycles with aliquoting to limit degradation and repeat synthesis.
• Waste minimization:
  • Use microscale assays and acoustic dispensing to significantly cut solvent and compound consumption.

Tradeoffs:

• While greener solvents can improve EHS profiles, they may alter solubility or assay performance. Validate alternatives experimentally before broad deployment.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation use is specified for AVLX-125. This product is supplied strictly for research use only.

General context for small molecules in R&D (not item-specific):

• Early-stage evaluation may include solubility, permeability (e.g., PAMPA, Caco-2), and stability in simulated biological matrices. Any formulation exploration (e.g., cyclodextrin complexes, lipid-based vehicles) must be guided by compound-specific data and is outside the scope of this product listing.

No medical or clinical claims are made or implied for this item.

Physical Properties

Item-specific properties (from Product Data):

• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Literature/computed values: Not available here due to absence of structural information. Typical values such as melting point, boiling point, density, refractive index, logP, pKa, and solubility can only be provided once the structure is known (via SMILES/InChI or verified literature for CAS 1786434-31-8).

General guidance for small-molecule screening compounds (not item-specific):

• Typical form: supplied as a solid or concentrated solution; solubility is often highest in polar aprotic solvents (DMSO, DMF) and alcohols (MeOH, EtOH).
• Solubility screening: begin with DMSO (e.g., 10–50 mM stock), then dilute into aqueous buffers with co-solvent (usually ≤1–2% DMSO v/v) while monitoring for precipitation.
• Hygroscopicity/photosensitivity: unknown for this item; protect from ambient moisture and light until specific guidance is available.

For authoritative, lot-specific properties, consult the CoA/Spec Sheet and SDS.

Quality and Grades

Item-specific quality information:

• Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret typical grades (general guidance, not item-specific):

• Screening or library grade: typically supplied to support biological assays and hit validation. Purity is often determined by HPLC/UPLC and confirmed by MS or NMR. Check the CoA for the exact assay method, purity threshold (e.g., area %), and residual solvent profile.
• Analytical grade or higher (e.g., HPLC grade for solvents) indicates tighter control of non-volatile residues and UV absorbance; for small molecules, look for detailed analytical data such as chromatographic purity, identity by HRMS, and NMR.

What to review on receipt:

• CoA/Spec Sheet: confirm identity (CAS, structure), lot-specific purity, counterions/salt form, residual solvents, and water content if provided.
• Stability notes: some screening compounds may be sensitive to hydrolysis, oxidation, or light. Verify any stabilizers or special handling (none specified for this item).

For this AVLX-125 lot, rely on the CoA/Spec Sheet for definitive purity, analytical methods, and acceptance criteria.

Reaction and Applications

This product is categorized as a small-molecule/library compound. In most programs, AVLX-125 would be used for screening, SAR exploration, or as a reference material rather than as a synthetic reagent.

Item-specific reactivity and named-reaction roles cannot be described without structural information. The following guidance is general and not item-specific:

• Screening workflows:
  • Prepare DMSO stocks (e.g., 10 mM), dispense into assay plates, and assess activity across biochemical or cell-based assays.
• Orthogonal confirmation:
  • Validate identity/purity of active lots by LC–MS and 1H NMR where feasible. Reassess potency after freeze–thaw cycles to rule out degradation.
• Stability checks:
  • Conduct quick stress tests (light exposure, pH 2–10, 37 °C) to flag liability (hydrolysis/oxidation) before larger studies.
• If synthetic use is intended:
  • Confirm functional groups and protective groups from the CoA/structure, then select compatible conditions. Absent structure, avoid strong redox conditions and extremes of pH.

For reaction development or derivatization, obtain the full structural specification (SMILES/InChI) to select appropriate catalysts, solvents, and temperatures.

Reaction Conditions

No item-specific reaction condition guidance can be provided for AVLX-125 due to the absence of structural and functional group information.

General notes (not item-specific):

• If derivatization is planned, select solvent and temperature based on functional group stability once known. Polar aprotic solvents (DMSO, DMF, MeCN) are common for coupling chemistry; ethers or esters (THF, EtOAc) for organometallic or neutral conditions.
• Typical screening of conditions may span 0–100 °C, with inert atmosphere when air/moisture sensitivity is suspected.
• Catalysts, bases, and acids should be chosen to avoid decomposition pathways indicated by preliminary stress tests or observed by LC–MS.

Expected yields, rates, or optimal catalysts cannot be estimated without the compound’s structure. Always validate on small scale first and monitor by LC–MS/UPLC.

Safety and Handling

Item-specific safety data:

• Signal word (GHS): Not specified for this item; refer to SDS.
• H-statements: Not specified for this item; refer to SDS.
• GHS classification and pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (not item-specific):

• Handle in a chemical fume hood with standard PPE: lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Avoid inhalation of dusts/vapors and skin/eye contact.
• Avoid incompatible conditions until known (strong oxidizers/reductants, acids/bases, and reactive metals may pose risks depending on functional groups; consult SDS once structure is confirmed).
• In case of exposure: rinse affected area with water for at least 15 minutes; remove contaminated clothing. Seek medical attention per SDS guidance.
• Spill management: contain and collect with inert absorbent; dispose according to institutional and local regulations.
• Fire safety: without known functional groups, assume combustible organic material; use CO2, dry chemical, or foam extinguishers as appropriate.

Always defer to the item’s SDS and your institution’s EHS protocols for authoritative safety information. Unknown hazards warrant conservative handling and minimal exposure.

Solvent Selection

Item-specific solvent guidance is not provided since the structure and functional groups are not disclosed. The following is general, literature-based guidance for dissolving small-molecule screening compounds (not item-specific):

• Primary stock preparation:
  • Start with anhydrous DMSO to prepare 10–50 mM stocks. Sonication and gentle warming (≤40 °C) can aid dissolution. Filter (0.2 µm PTFE) if particulates persist.
• Secondary options:
  • DMF, NMP, and alcohols (MeOH, EtOH, i-PrOH) are strong alternatives when DMSO solubility is limited.
• Aqueous work:
  • Dilute DMSO stocks into buffers slowly with vortexing to minimize precipitation. Keep final DMSO at ≤1–2% v/v for most biochemical assays and cell systems; verify tolerance for your assay.
• Solubility enhancers:
  • Cosolvents (PEG-400, propylene glycol), cyclodextrins, or mild surfactants (e.g., 0.01–0.05% Tween-80) can be evaluated if precipitation remains an issue.
• Avoid:
  • Strong acids/bases or reactive nucleophiles until functional group compatibility is known.

Document the final solvent composition in your assay records and verify clarity visually before use.

Storage and Reconstitution

Item-specific storage and shipping (from Product Data):

• Storage conditions: Store at −20 °C.
• Shipped in: Ice chest + ice pads.

General guidance (not item-specific):

• Protect from light and moisture in tightly sealed, inert-atmosphere containers when feasible. Allow to equilibrate to room temperature in a desiccator before opening to minimize condensation.
• Reconstitution: prepare DMSO stock solutions (e.g., 10–50 mM). If aqueous use is required, dilute slowly into buffer to a final DMSO content typically ≤1–2% v/v, verifying solubility and clarity.
• Aliquoting: divide into single-use portions to avoid repeated freeze–thaw cycles. Record thaw cycles and discard aliquots showing precipitation or discoloration.
• Stability: Without structure-specific data, assume improved stability when frozen and protected from light/air. For definitive shelf-life and retest periods, consult the CoA/Spec Sheet for your lot.

Note: For research use only. Not for human or veterinary use.

Structure and Identity

Brief overview: AVLX-125 is listed as a small-molecule library member intended for research screening and discovery workflows. Item-specific structure details are not provided in the product data.

Item-specific facts (from Product Data):

• SKU: A1437516
• Product Name: AVLX-125
• CAS: 1786434-31-8
• Storage: Store at −20 °C
• Shipping: Ice chest + ice pads
• Research use: For research use only

Identifiers and descriptors:

• Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
• Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
• SMILES: Not specified for this item; refer to CoA/Spec Sheet.
• InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

• Without a provided structure (SMILES/InChI), ring systems, functional groups, and stereochemistry cannot be described for this item. Please consult the Certificate of Analysis (CoA), Spec Sheet, or SDS for the definitive structure and identifiers tied to CAS 1786434-31-8.

Practical identity notes:

• Use the CAS number with your internal databases or literature resources to cross-reference structure and synonyms, then reconcile with the CoA provided with your lot for confirmation.

Synthetic Utility

Item-specific synthetic transformations cannot be described for AVLX-125 without structural information. If you intend to use the material as a building block or intermediate, please obtain the full structure from the CoA/Spec Sheet.

General considerations for small-molecule building blocks (not item-specific):

• Functional group compatibility dictates use in cross-coupling (e.g., Suzuki, Buchwald–Hartwig), carbonyl chemistry, nucleophilic/electrophilic substitutions, or heterocycle-forming condensations.
• Protecting-group strategy and chemoselectivity should be planned based on heteroatom content and acidity/basicity.
• Analytical confirmation: verify integrity pre- and post-reaction by LC–MS and NMR, particularly if multiple freeze–thaw cycles have occurred during storage.

For definitive synthetic guidance, consult the structural data and any available spectral characterization for your specific lot.

Target Specificity

Not applicable. AVLX-125 is provided as a small-molecule library compound, not a biological macromolecule or antibody. No target annotations, epitope details, or species reactivity are provided in the product data. Any target engagement must be established experimentally in your assay system.